Century Therapeutics, Inc. (IPSC) Return on equity 2022–2025
Century Therapeutics, Inc. (IPSC) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-6.0%FY2025 · since FY2022: -43.2% → -6.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -6.0% | +72.4 pp |
| FY2024 | -78.4% | -4.5 pp |
| FY2023 | -74.0% | -30.7 pp |
| FY2022 | -43.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More IPSC financial trends
IPSC RevenueIPSC Net incomeIPSC Net marginIPSC Gross profitIPSC Gross marginIPSC Operating incomeIPSC Operating marginIPSC Operating cash flowIPSC Free cash flowIPSC Capital expendituresIPSC Stock buybacksIPSC Dividends paidIPSC Total assetsIPSC Total liabilitiesIPSC Shareholders’ equityIPSC overview →